NCT02717364View on ClinicalTrials.gov

Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma

CompletedOBSERVATIONAL
Enrollment

556

Participants

Timeline

Start Date

August 27, 2015

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2018

Conditions
Melanoma
Trial Locations (2)

1018202

Local Institution, Chiyoda-ku

Unknown

Local Institution, Tokyo

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY